documents: FDA-2024-N-5331-0003

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2024-N-5331-0003 FDA FDA-2024-N-5331 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee; Amendment of Notice—Extended-Release/Long-Acting Opioid Analgesic Postmarketing Requirement Notice Announcement 2025-04-21T00:00:00Z 2025 4 2025-04-21T00:00:00Z 2025-05-05T03:59:59Z 2025-05-13T09:00:48Z 2025-06787 0 0 0900006486aa4374

Links from other tables